60 Degrees Pharma Announces Closing of $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
The aggregate gross proceeds to the Company from the offering were approximately $1.075 million, before deducting the placement agent fees and other offering expenses payable by the Company. The total ...